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ABSTRACT
There is a significant amount of evidence to suggest that human tumors are 
driven and maintained by a sub-population of cells, known as cancer stem cells (CSC). 
In the case of head and neck cancer, such cells have been characterised by high 
expression levels of CD44 cell surface glycoprotein, while we have previously shown 
the presence of two diverse oral CSC populations in vitro, with different capacities 
for cell migration and proliferation. Here, we examined the response of oral CSC 
populations to ionising radiation (IR), a front-line measure for the treatment of head 
and neck tumors. We show that oral CSC initially display resistance to IR-induced 
growth arrest as well as relative apoptotic resistance. We propose that this is a 
result of preferential activation of the DNA damagerepair pathway in oral CSC with 
increased activation of ATM and BRCA1, elevated levels of DNA repair proteins RAD52, 
XLF, and a significantly faster rate of DNA double-strand-breaks clearance 24 hours 
following IR. By visually identifying CSC sub-populations undergoing EMT, we show 
that EMT-CSC represent the majority of invasive cells, and are more radio-resistant 
than any other population in re-constructed 3D tissues. We provide evidence that 
IR is not sufficient to eliminate CSC in vitro, and that sensitization of CD44hi/ESAlow 
cells to IR, followed by secondary EMT blockade,could be critical in order to reduce 
primary tumor recurrence, but more importantly to be able to eradicate cells capable 
of invasion and distant metastasis.
INTRODUCTION
There has been an increasing amount of evidence in 
the recent years, suggesting that tumor populations with 
stem cell properties are responsible for recurrence after 
tumor therapy. Such populations have been described 
in both hematopoietic as well as in solid malignancies 
including breast, brain, pancreas, colon, and those of 
the head and neck [1–9]. Although their gene expression 
profiles are significantly different, all share common 
characteristics of stem cell behaviour. For example, they 
can replenish the tumor that they have originated from, as 
well as being able to reseed tumors when transplanted at 
limiting dilutions in vivo. CSCs are therefore regarded as 
being the most important target to achieve complete tumor 
eradication [10, 11]. 
In cancers of the head and neck, conventional 
irradiation is routinely used as means of therapy. Since the 
regulation of the DNA damage response (radio-sensitivity) 
depends on key checkpoint proteins, it is heavily influenced 
by cell cycle dynamics. As opposed to a single radiation 
dose, fractionation of the treatment ensures that cells 
will eventually be exposed in all different phases of the 
cell cycle during subsequent treatments. This is why 
ionising radiation treatment typically involves fractioned 
low-level radiation (usually 2Gy) over a period of time, to 
reach a final dose of up to 70Gy [12]. Ionizing radiation 
induces extensive DNA damage (mainly in the form of 
double strand breaks; DSBs) which initiates the pathway 
for genomic repair, or induces irreversible exit from the 
cell cycle that leads to cell death. Immediately after the 
induction of DSBs, the activation of ATM and ATR 
complexes act both as recruiters of additional substrates, 
as well as scaffolds for the assembly of additional active 
complexes [13]. ATM activates, via phosphorylation, 
additional downstream substrates including H2AX histone, 
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an important regulator of the DNA damage response 
(DDR) mechanism that is recruited to sites of DSBs. In 
fact, phosphorylated H2AX (γH2A.X) has been extensively 
used not only as a marker of DNA damaged cells, but also 
as an indicator for the efficiency of repair following DNA 
damage.
Knowledge of the response of cancer stem cells to 
ionizing radiation is limited to only a few tumor types, but 
nonetheless suggests that CSCs are more radio-resistant 
than the remaining bulk of tumor cells. In breast tumor cell 
lines, stem cell-enriched mammospheres (CD24low/CD44hi) 
show greater clonogenic capacity and diminished numbers 
of γH2A.X foci following radiation, and a lower-level 
induction of reactive oxygen species (ROS) after exposure 
to IR [14]. A separate study has also shown that stem cells 
derived from breast tumor cell lines have low levels of 
ROS and possess an anti-oxidant gene expression profile 
[15]. In addition, Wnt/β-catenin is another mechanism that 
mediates the radio-resistance of mammary progenitor cells, 
as suggested by two separate studies performed in murine 
cells [16, 17]. In glioma, evidence is yet contradictory 
since stem cells (CD133+) have shown radio-resistance by 
differential regulation of the DNA damage response when 
exposed to clinically relevant doses of gamma irradiation 
[18], while others have observed little differences in DNA 
repair between glioma CD133+ cells in larger cohorts of 
glioma cell lines [11]. 
We have successfully established protocols for the 
isolation and maintenance of CSC populations from oral 
carcinoma cell lines. Further to that, we have shown the 
existence of a distinct sub-population with a migratory 
behaviour which is believed to represent invasive 
tumor cells in vivo [19]. This is particularly relevant 
to therapeutic resistance as this sub-population is also 
thought to be responsible for the metastatic behaviour 
of human tumors. In this report, we have examined the 
response of oral cancer cells to clinically relevant doses 
of ionising radiation, and have found that oral tumor cells 
with stem cell properties show enhanced resistance to 
growth arrest and early apoptotic stimulation as a result 
of IR treatment. Although all CSC display resistance to 
IR, those with a mesenchymal expression profile (CD44hi/
CD24low) show a greater level of DNA repair following 
treatment. By genetic labelling of oral cancer cell lines, 
we show that mesenchymal CSCs not only comprise the 
majority of the invasive oral tumor cells, but are also able 
to resist the DNA damaging effects of ionising radiation in 
three-dimensional organotypic tissue.
RESULTS AND DISCUSSION
Oral CSC are more resistant to IR-induced 
growth arrest
Oral CSC populations can be distinguished by the 
expression levels of cell surface marker CD44 [8], and 
sub-categorised to motile or non-motile depending on the 
levels of ESA expression [19]. To investigate each separate 
population of oral tumor cells, we first used fluorescence 
activated cell sorting (FACS) with a combination of 
anti-CD44 and anti-ESA antibodies to isolate: a) oral 
CSC, characterized by a CD44hi/ESAhi profile, b) oral 
cancer stem cells undergoing EMT characterized by a 
CD44hi/ESAlow profile, c) differentiating oral tumor cells 
characterized by a CD44low/ESAhi profile, and d) oral 
tumor cells that were sorted at random (RS) (Figure 1Ai). 
All cells were allowed to grow in culture for five days 
prior to being exposed to a single dose of ionising 
radiation. To ascertain that cells retained expression of 
CD44 throughout culture, each cell fraction was tested for 
CD44 total protein levels prior to treatment (Figure 1Aii). 
The CD44 antibody, used for immunoblotting, binds the 
epitope which is present in the distal region of all CD44 
isoforms, therefore recognizing the lower molecular 
weight CD44 isoform, lacking the variant exons, as 
well as the other CD44 isoforms (CD44v) of higher 
molecular weights [19, 25]. CD44low cells express the 
least amount of CD44, when compared to both CD44high 
and CD44high/ESAlow cells, while CD44high/ESAlow cells 
express the standard CD44 isoform in much higher levels 
when compared to CD44high populations, in line with our 
previous observations [19]. Cells were treated with varying 
doses of IR and their viability was monitored for the next 
four days. We found that CD44low/ESAhi oral tumor cells, 
which represent cells with the least self-renewal capacity, 
were more sensitive to growth arrest (Ic50: 1Gy) compared 
to the oral CSC populations (CD44hi/ESAlow Ic50: 1.5Gy; 
CD44hi/ESAhi Ic50: 1.6Gy) (Figure 1B). In addition, for 
both CA1 and Luc4 HNSCC cell lines, oral CSC had 
a slight advantage in clonogenic capacity two weeks 
following a single dose of 2Gy (Figure 1C). The lack of 
greater difference between those fractions (Figure 1Ci, ii) 
might be explained by the long culture periods which can 
allow sufficient time for the self-renewing cells of the 
CD44low/ESAhi fraction to produce equally large colonies. 
However, we noticed that the sphere forming capacity of 
CD44hi/ESAlow cells (motile CSC) remained relatively 
intact following 2 Gy of IR. In contrast, both CD44hi/
ESAhi and CD44low/ESAhi had a greater reduction in 
sphere-forming ability following IR treatment (Figure 1D 
i and ii). 
CSC show preferential activation of DNA 
damage and repair associated proteins
Ionising radiation is a strong inducer of both single 
strand (ss) and double strand (ds) DNA breaks, which in 
turn lead to activation of cell cycle checkpoints, such as 
ATM and ATR which regulate downstream checkpoint 
proteins CHK1 and CHK2 [26–28]. Successful triggering 
of DNA damage checkpoints leads to the activation of 
DNA repair, which ultimately determines cell fate. In 
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Figure 1: Oral CSC are more resistant to IR-induced growth arrest. (Ai) Typical flow cytometry profile of CA1 cells stained 
with CD44-PE/ESA-APC. All three populations CD44low/ESAhi, CD44hi/ESAhi, and CD44hi/ESAlow were flow sorted and grown for five 
days. (Aii) Immuno-blot against anti-CD44, to verify population purity prior to irradiation treatment. (B) Epithelial stem cell populations 
are more resistant to radiation-induced growth arrest. All populations were treated individually, after flow sorting, with varying doses 
of γ-irradiation and proliferation was measured. CD44low/ESAhi was the most sensitive population to growth arrest (Ic50: 1Gy), when 
compared to the oral CSC populations (CD44hi/ESAlow Ic50: 1.5Gy; CD44hi/ESAhi Ic50: 1.6Gy). (Ci) Clonogenic assays were performed to 
measure the capacity of each population to form colonies after a 10-day period. There is a slightly reduced sensitivity of CSC in response to 
γ-irradiation, but the differences are not statistically significant (Cii, Ciii). (D) The sphere forming capacity of CD44hi/ESAlow cells (motile 
CSC) remained relatively stable following 2 Gy of IR. Both CD44hi/ESAhi and CD44low/ESAhi almost completely lost this ability following 
IR. *P < 0.05, **P < 0.01, ***P < 0.001.
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this respect, we sought to investigate the efficacy of the 
DNA damage response and repair in sub-populations of 
HNSCC tumor cell lines. We initially investigated protein 
levels of different mediators of the DNA damage and 
repair pathway following irradiation of all sub-populations 
(Figure 2A, 2B; digital densitometry analysis on Figure 
S1B), and observed a preferential activation of p-CHK2 
in CSC populations suggesting an enhanced response to 
DNA damage, which is often linked to radioresistance. 
CHK2, as well as other DNA damage response (DDR) 
proteins are highly expressed in both human embryonic 
stem cells (ES) and iPS cells, which accords with their 
proclivity for efficient DNA repair [29]. In stem cell-like 
enriched populations of nasopharyngeal carcinoma cells, 
c-MYC positively regulates the expression of CHK1 and 
CHK2 to confer radioresistance [30], supporting the idea 
that an enhanced DDR may confer a survival advantage to 
CD44hi/ESAhi and CD44hi/ESAlow cells. CSC populations 
also showed preferential activation of RAD52, BRCA1, 
in the early time point (1 h) following IR, while XLF was 
consistently upregulated in CSC fractions throughout the 
irradiation time-course (Figure 2B; densitometry analysis 
on Figure S1B). It is thought that proliferating cells at the 
G1 phase of the cell cycle utilise the non-homologous end 
joining (NHEJ) pathway to repair DNA damage, whereas 
dividing cells at the G2 phase will utilise the homologous 
recombination (HRR) pathway for DNA repair [31]. 
The RAD11-RAD52 epistasis group is responsible 
for the repair of DSBs in yeast, while overexpression 
of the human gene can confer γ-ray resistance and 
induced homologous intra-chromosomal recombination 
in cultured monkey cells [32]. It is also an alternative 
mechanism of repair during HRR, in cells with low or 
deficient expression of BRCA1 and/BRCA2 [33]. More 
importantly, the elimination of RAD52, by use of peptide 
aptamer, eliminates cancer stem and progenitor cells in 
the blood due to excessive accumulation of spontaneous 
lethal DBs without addition of genotoxic treatment [34]. 
The elevated levels of XLF and RAD52 prior to IR 
treatment, or in response to IR, respectively, may suggest 
that both proteins may be novel targets for oral CSC, 
the inhibition of which could lead to selective killing of 
those cells by means of spontaneous DSB induction and/
or amplification of DNA damage following IR. Both 
CSC populations appear to have elevated levels of DDR 
proteins responsible for both NHEJ (XLF), as well as 
HRR (RAD52, BRCA1), suggesting that possibly both 
CSC sub-types are intrinsically capable of utilising either 
pathway for DNA repair. 
Irradiation doses that can cause significant levels of 
DNA damage, also lead to cell death via apoptosis, due 
to the presence of extensive unrepaired DNA lesions. 
We therefore measured the levels of apoptotic markers 
in all different fractions at various time points following 
radiation. Although we did not detect any cleavage of 
PARP or Caspase-9 during the first 18 hours following 
irradiation (Figure S1), we have seen a sensitisation of 
CD44low cells 48 h following irradiation with 2Gy. At that 
time point, CD44low/ESAhi and CD44low/ESAlow cells show 
significantly reduced levels of cleaved caspase proteins 
(Figure 2C, digital densitometry shown on Figure S1C). 
Last, by AnnexinV/DAPI staining (Figure 2D), performed 
48 hours after 2Gy IR, we further confirmed the relative 
apoptotic resistance of both CSC populations, when 
compared to CD44low control cells.
CSC have an increased rate of DSB clearance 
after ionising radiation
The protein expression profile of CSC suggests 
a preferential activation of DNA repair proteins that 
can potentially contribute to an improved rate of DNA 
repair following IR, hence providing a better chance for 
survival. Therefore, we tested the rate of DSB clearance 
from each of those populations by counting the number 
of γ-H2A.X foci after IR. As previously, cells were flow 
sorted and treated with low-dose radiation of 1Gy or 2Gy 
and then examined 1 h and 18 h post-IR for the presence 
of γ-H2A.X and p-CHK2 positive foci (Figure 3Ai, ii). 
The presence of the phosphorylated form of histone 
H2A at sites of double strand breaks, is required for the 
recruitment of proteins essential for the process of DNA 
repair [35, 36]. As is evident from the images, DSB foci 
accumulate in both CA1 and Luc4 cells within an hour 
after irradiation. The rate of DNA repair, or the rate of 
reduction in the number of DSB foci, can be assessed by 
measuring the remaining γ-H2A.X foci several hours after 
treatment. We had already seen that the 18 h time-point is 
too early for apoptotic stimulation to result from radiation 
treatment (Figure 2C), excluding the possibility that cells 
with high levels of DNA damage foci might be lost by 
death. By counting the remaining double strand breaks in 
all different sub-populations we find that CD44hi/ESAhi 
and CD44hi/ESAlow cells displayed a reduced amount 
of DNA double strand breaks, suggesting quicker and/
or more efficient DNA repair (Figure 3Bi, ii). In line 
with our observations, Dao et al. has also proposed that 
glioblastoma stem cells (CD133+) display accelerated 
DNA repair [18]. These observations suggest that the two 
subpopulations of CSC are more capable of responding 
to irradiation-induced double strand breaks and could 
potentially be more capable of repopulating a tumor 
following treatment by ionising radiation. 
CD44hi/ESAlow is the invasive population of oral 
tumor cells 
Although cancer stem-like cells with a mesenchyme 
expression profile are radio-resistant when cultured 
independently of other cells, in vivo tumors possess a 
mixture of cells permitting interactions between the 
sub-populations of cancer cells and the stromal cells. 
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We therefore decided to maintain the proportion of the 
parental cell lines, but in such a way that CD44hi/ESAlow 
cells could be easily tracked. CA1 and Luc4 lines were 
stably transduced with either pSIN-MCS (empty control) 
or pSIN-EGFP retroviral vectors (Figure 4A). The pSIN-
MCS transduced cells were sorted to completely deplete 
them of the CD44hi/ESAlow population, while the pSIN-
EGFP transduced cell lines were flow sorted to isolate 
only CD44hi/ESAlow cells (Figure 4A). Finally, both types 
were mixed at a ratio mimicking that of the parental cell 
line. To establish the stability of our system, we let the 
cells grow in culture for up to 14 days. By 7 days of 
culture, the very distinct phenotype of mesenchyme-like 
elongated cells (CD44hi/ESAlow) cells was almost always 
accompanied by clear expression of EGFP marker protein 
(Figure 4Bi, Figure 4Ci) whereas epithelial cells did not 
display expression of EGFP. Cells with an epithelial stem-
like morphology, small round cells with high nuclear/
cytoplasmic ratio, and organised into tight compact 
colonies termed holoclones [37, 38], were almost always 
seen as EGFP(−) (clear depiction of a holoclone EGFP(−) 
shown in Figure 4Ci).
By 14 days of culture we noticed a minority of 
EGFP(+) cells with epithelial morphology as well as a 
significant number of EGFP(−) cells with a mesenchymal 
phenotype. Interestingly, using the prolonged 14 day 
culture we were able to visualise the dynamics of 
epithelial to mesenchymal transition (EMT) by tracing the 
EGFP(−) CD44hi/ESAlow cells (2.8% new EMT ratio Figure 
4Bii left; population Q3–4) as well as of mesenchyme to 
Figure 2: CSC show preferential activation of DNA damage and repair associated proteins. Western Blot analysis of protein 
extracts from CA1 cells. All three populations were flow sorted, then allowed to grow for 5 days prior to a single exposure to 2Gy IR. Cells 
were allowed to recover prior to being lysed at 1 hour and 18 hours IR. (A) Total cell proteins were immuno-blotted against anti-pCHK2, 
γH2A.x, while β-actin was used as protein loading control. There is preferential activation of both proteins, specifically γH2A.x in CSC 
populations following IR treatment. (B) Total cell proteins were immuno-blotted against anti-pATM, anti-pATR, anti-RAD50, anti-RAD52, 
anti-pBRCA1, ant-XLF, while β-actin was used as protein loading control. Both types of CSC populations show preferential activation of 
RAD52, p-BRCA1, and XLF suggesting activation of the DNA repair pathway. (C) Immuno-blot against anti-cleaved Caspase3 following 
IR treatment with 2Gy. Longer time points revealed an apoptotic response for CA1 cells, with CSC populations showing a later response 
to IR treatment. Control CD44low/ESAhi cells show dramatic sensitisation to apoptosis starting 72 hours after 1Gy IR, while both CSC 
populations show a delayed response starting at 48 hours after 5Gy IR. β-actin was used as protein loading control. (D) AnnexinV/DAPI 
staining was performed on all separate fractions 2 days following treatment with 2Gy to detect live (AnnexinV(−)/DAPI(−)), early apoptotic 
(AnnexinV(+)/DAPI(−)), late apoptotic (AnnexinV(+)/DAPI(+)), and dead (AnnexinV(−)/DAPI(+)) cells. CD44low/ESAhi and CD44low/ESAlow 
populations show preferential resistance to early apoptosis when compared to CD44low/ESAlow control cells. *P < 0.05, ***P < 0.001
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Figure 3: CSC have an increased rate of DSB clearance after ionising radiation. Cells were treated with 2Gy IR and immuno-
stained to investigate the level of DNA damage and repair following treatment. (A) CA1 cells were fixed at set time-points (1 h, 18 h) 
following treatment. Double strand DNA breaks (DSB foci) were measured by immunofluorescence against anti- γH2A.x and anti-pCHK2. 
Cells were counterstained with DAPI for nuclear visualisation. DSB foci rapidly accumulated in CA1 cells within an hour after irradiation, 
regardless of the type of population that was exposed to IR. DNA repair, or DSB foci clearance, was assessed by measuring the remaining 
γ-H2A.X foci 18 hours post-IR. CD44hi/ESAhi and CD44hi/ESAlow cells displayed a reduced amount of DNA double strand breaks, suggesting 
quicker and/or more efficient DNA repair. (B) DSB foci were counted in each population for both CA1 and Luc4 cells in ImageJ using the 
cell counter tool. Each data point represents the average amount of nuclear DSB foci (double-positive for γH2A.x and p-CHK2) per field. 
An average of approx. 10 cells was quantified per high power field. Data are representative of two separate experiments performed in two 
replicate wells each. *P < 0.05, **P < 0.01, ***P < 0.001.
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epithelial transition (MET) by tracing the EGFP(+) CD44hi/
ESAhi (0.4% Figure 4Bii right; population Q2–4) cells. 
The MET rate appeared to be higher for Luc4 (1.2% 
Figure 4Cii right; population Q2–4) cells compared to 
CA1 cells, while the rate of EMT seemed to be similar 
to both types of cells. Continuous monitoring of both 
reconstituted cell lines showed that a part of the original 
CD44hi/ESAlow population remained permanently at a 
mesenchymal state while the remaining population was 
recycled within the parental cell line, in agreement with 
our previous work showing the presence of uni-potent and 
bi-potent CD44hi/ESAlow cells [19].
We then investigated the behaviour of the CD44hi/
ESAlow sub-type in physiologic 3D culture conditions that 
mimic in vivo tissue architecture. Therefore, we used a 
collagen/matrigel organotypic matrix oral epithelia to 
culture the CA1_EGFP-EMT and Luc4_EGFP-EMT cell 
lines for a period of 10 days in the presence of fibroblasts 
which comprised the ‘stroma’. We found that 86% ± 2.8% 
of EGFP(+) cells in the CA1 line, and 92% ± 9.1% of 
EGFP(+) cells in the Luc4 line were able to invade through 
the stroma of these organotypic cultures (Figure 5A). 
Furthermore, those cells comprised the majority of all 
invasive cells for both cell lines providing, for the first 
time to our knowledge, visual evidence that CD44hi/ESAlow 
cells is the invasive population of oral tumor cells. From 
our 2D culture observations, we show that the majority 
of EGFP(+) cells are maintained in a mesenchymal state 
characterised by CD44hi/ESAlow profile even after 14 days 
in culture. Similarly, in 3D organotypic tissue, we find 
that genetically modified CD44hi/ESAlow cells (EGFP(+)) 
also remain Vimentin+ by 80% ± 6.4% within the 14 
days of culture (Figure 5A (lower panel) and Figure S3). 
As a result, we propose that by selecting CD44hi/ESAlow 
populations from oral tumor cell lines, we can identify 
the population of cells responsible for tumor invasion in 
both cell lines. The remaining Vimentin+ cells comprised 
epithelial cells that had undergone EMT (Vimentin+/
EGFP−; Figure S3) during the course of tissue formation, 
as well as stromal fibroblasts. This agrees with our 
observations (Figure 4Aiii; population Q3–4) showing 
that new EMT becomes evident by the 14th day of culture. 
We further tested this by producing lines with a) 
0% CD44hi/ESAlow and b) 10% of CD44hi/ESAlow and c) 
20% of CD44hi/ESAlow and have cultured each for 14 days 
in organotypic cultures. In this system, the rate of EMT 
can be indirectly measured by the amount of invading 
cells that are EGFP(−). The CA1 parental line without any 
CD44hi/ESAlow cells showed remarkable invasion ability, 
driven by tumor cells (EGFP(−)) that have undergone EMT 
during that period. Surprisingly, this invasion index was 
not further increased regardless of the amount of CD44hi/
ESAlow cells that were injected into the parental cell line 
(Figure 5Bi, ii). However, in the 10% variant, the majority 
of invading cells were EGFP(+), while in the 20% variant 
of the CA1 line, almost all invading cells were EGFP(+), 
suggesting that only very few cells invaded into the 
organotypic tissue as a result of new EMT (Figure 5Bii). 
Our results show that the rate of EMT is reduced and/
or inhibited in the presence of an established CD44hi/
ESAlow population and therefore, suggesting a feedback 
mechanism that maintains an equilibrium between 
CD44hi/ESAlow and CD44hi/ESAhi populations and results 
in a stable invasion index in all cases. This indicates that 
even with complete eradication of CD44hi/ESAlow cells, 
the invasive tumor sub-populations can be replenished 
quickly from the established tumor epithelium. In the 
case of many carcinomas, EMT is induced, or assisted, by 
growth factor signals originating from tumor associated 
stroma (i.e. PDGF, TGF-β, EGF, HGF) [39–41], or even 
by the deposition of ECM proteins like fibronectin, 
as is the case in mammary epithelium [7]. It would be 
interesting to know the involvement of varying stromal 
cells in the EMT process but it appears that combined 
treatments, including both selective eradication of CD44hi/
ESAlow cells as well as secondary blockade of the EMT 
process may be necessary to inhibit tumor invasion and 
subsequent metastasis. Interestingly the remaining small 
fraction of EGFP(+) cells were found in the upper layers 
of the re-constituted epithelium suggest that MET is 
occurring during 3D culture, which is consistent with our 
observations on 2D cultures (Figure 4Bii and Figure 4Cii) 
where MET had occurred during a 14-day period.
Invading tumor cells are radio-resistant in 
organotypic cultures
As we were able to identify and track the EMT 
population of CSC in 3D organotypic culture, we 
wanted to examine its behaviour in response to IR in a 
physiological 3D environment. We cultured CA1_EGFP-
EMT cells as 3D organotypic tissues for 10 days to allow a 
malignant epithelium to be established. Then, we exposed 
the tissues to a single IR dose of 2Gy and, to examine the 
effect of IR treatment, allowed the cells to return to normal 
conditions for 1 hour or 72 hours. 2Gy irradiation induced 
DSB within 1 hour, a rate similar to that observed in 2D 
cultures (Figure 6A, 6B). Three days following irradiation 
treatment, we observed that all invaded cells had been 
able to clear DSB more efficiently when compared to all 
other cells in the 3D epithelium (Figure 6B). We did not 
see significant differences between the amounts of DSB 
remaining in EGFP− (new EMT CSC) or EGFP+ (pre-
established EMT CSC) cells. Taken together, these data 
support our notion that the CD44hi/ESAlow population 
is the invasive population of tumor cells in 3D tissue 
and, further to that, also displays enhanced DNA repair 
activity. In a recent report it was shown that non-small 
cell lung carcinoma cells that survive ionizing radiation, 
have a complex phenotype which included properties of 
CSC and EMT markers [42], which supports the notion 
that CSC populations, and specifically those cells with 
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Figure 4: Generation and characterisation of EMT-CE cell lines. CA1 and Luc4 parental cell lines were transduced with either 
pSIN-MCS or pSIN-EGFP retroviral vectors (A). pSIN-MCS transduced cells were completely depleted of CD44hi/ESAlow population, 
while the pSIN-EGFP transduced cell lines were flow sorted and only CD44hi/ESAlow were isolated. Both types were mixed at a ratio which 
mimicked that of the parental wild-type cell line. (B, C) Cells were later grown for up to 14 days. By 7 days of culture, the very distinct 
phenotype of mesenchyme-like (CD44hi/ESAlow) cells was almost always accompanied by clear expression of EGFP marker protein (Bi, Ci) 
whereas epithelial cells did not display expression of EGFP. By 14 days of culture, a minority of EGFP(+) cells with epithelial morphology 
as well as a significant number of EGFP(-) cells with a mesenchymal phenotype became evident. After prolonged culture we were able to 
visualise the dynamics of epithelial to mesenchyme transition (EMT) by tracing the EGFP(−) CD44hi/ESAlow cells (Bii, Cii) as well as of 
mesenchyme to epithelial transition (MET) by tracing the EGFP(+) CD44hi/ESAhi cells. The MET rate appeared to be higher for Luc4 cells 
compared to CA1 cells, while the rate of EMT seemed to be similar to both types of cells. Continuous monitoring of both reconstituted 
cell lines showed that a part of the original CD44hi/ESAlow population remained permanently at a mesenchymal state while the remaining 
population was recycled within the parental cell line.
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Figure 5: CD44hi/ESAlow is the invasive population of oral tumor cells. The EMT-CE cells derived from the CA1 line were 
cultured in 3D collagen:matrigel gels for a total period of 10 days. (A) Gels were immuno-stained with anti-EGFP, anti-Cytokeratin, and 
anti-Vimentin. DAPI was used as a counterstain to visualise the nucleus. A large majority (86% ± 2.6%) of EGFP(+) CA1 cells was able to 
invade through the stroma of organotypic cultures. Furthermore, EGFP(+) cells comprised the majority of all invasive cells for both CA1 
and Luc4 cell lines. 80% ± 6.4% of invasive EGFP(+) was also positive for Vimentin. (B) EMT-CE CA1 line was re-constituted with varying 
percentages of EMT cells (0%, 10%, and 20% CD44hi/ESAlow) and cultured for 14 days on top of 3D collagen:matrigel organotypic cultures. 
CA1 parental line without any CD44hi/ESAlow cells showed invasion driven by tumor cells that have undergone EMT while growing on 
the organotypic tissue (EGFP−). The invasion index is not further increased regardless of the amount of CD44hi/ESAlow cells that are added 
to the parental cell line (Bi, Bii). In the 10% variant the majority of invading cells are EGFP(+), while in the 20% variant of the CA1 line, 
almost all invading cells were EGFP(+), suggesting that only very few cells invaded into the organotypic tissue as a result of new EMT. *P 
< 0.05, **P < 0.01, ***P <0.001.
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Figure 6: Invading tumor cells are radio-resistant in organotypic cultures. To assess the differential response of each population 
to IR treatment in a physiological 3D environment, EMT-CE lines were grown on top of collagen:matrigel (3:1 ratio) gels for 10 days prior 
to being exposed to a single dose of 2Gy IR. Gels were allowed to grow for 1 hour and 3days post-irradiation. (A) The tissues were stained 
with anti-EGFP and anti- γH2A.x and DSB foci were counted in each condition. (B) Each data point represents the average amount of 
nuclear DSB foci (positive for γH2A.x) per field. An average of approx. 10 cells was quantified per high power field. Data are representative 
of two separate experiments performed in two replicate wells each. All invasive cells, regardless of their prior status (EMT or epithelial), 
showed enhanced DSB clearance 3 days following IR treatment with 2Gy. *P < 0.05, **P < 0.01, ***P < 0.001.
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EMT traits, can show relative resistance to the effects of 
IR. Interestingly, we also observed that IR treatment in 
2D cultures stimulated the transition of EMT CE cells 
towards a more epithelial phenotype, suggesting the 
induction of MET (Figure S2), while increasing the IR 
dose past 2Gy made little difference to this effect. The 
same dose of IR (2Gy) can also alter the metastatic and 
migratory ability of breast tumor cells in a time-dependent 
manner [43]. Those observations could be of importance 
since, in combination with the radio-resistance of EMT 
cells in a 3D environment, IR treatment may influence 
the capability of resistant EMT cells to be re-established 
(by re-epithelisation) at local metastatic sites within the 
regions affected by IR treatment.
We have shown that a defined CD44hi/ESAlow 
population of head and neck tumour cells is capable of 
invasion into 3D organotypic tissues, and that this population 
is resistant to therapeutically relevant doses of IR. This can 
be attributed to enhanced clearance of IR-induced DNA 
damage, possibly due to up-regulation of certain DDR 
proteins, some of which could potentially also serve as 
novel targets for the sensitisation of CSC to IR treatment. 
The presence of the motile CD44hi/ESAlow population is not 
a pre-requisite for cell invasion as invasion (and possibly 
metastasis) could still occur via the observed generation 
of de novo EMT which led to the quick re-establishment 
of the motile CD44hi/ESAlow fraction. It is possible that 
sensitization of CD44hi/ESAlow cells to IR, followed by 
secondary EMT blockade could be more beneficial in 
inhibiting cell invasion and subsequent metastasis.
MATERIALS AND METHODS
Cell culture
Primary HNSCC derived cell lines [19]: CA1, Luc9, 
and Luc4 were maintained in FAD medium consisting 
of DMEM supplemented with 25% Ham’s F12 medium 
(Gibco, Invitrogen), 10% foetal calf serum (FCS), 1% 
penicillin/streptomycin (Invitrogen, Paisley, UK), and 
various mitogens (0.4 µg/ml hydrocortisone, 0.1 nM 
cholera toxin, 5 µg/ml transferrin, 20 pM lyothryonine, 
0.18 mM adenine, 5 µg/ml insulin and 10 ng/ml EGF). All 
cells were grown at 37°C in a humidified atmosphere of 
10% (DMEM/RM+) or 5% (K-SFM, EpiLife) CO2/95% air. 
Organotypic cultures
Collagen and matrigel were mixed at a ratio of 5.25 
volumes (collagen type I) and 1.75 (Matrigel), with 1 
volume of 10 × DMEM, 1 volume FBS, and 1 volume of 
stromal cell suspension (5 × 105 human foetal fibroblasts, 
or normal oral fibroblasts). The mixture was added into 
wells of a 24-well plate (1 ml/well) pre-coated with diluted 
collagen type I for 1 hr at 37°C in a humidified atmosphere 
of 10% (1:100 in PBS). The mixture was left to set for 1 h 
at 37°C in a humidified atmosphere of 10%. Next, 1 ml 
of the cancer cell suspension (5 × 105 cancer cells per ml) 
was added on top of the gels and left 1 h at 37°C in a 
humidified atmosphere of 10%. Next day, gels were raised 
at the air liquid interface, by placing on top of metal grids. 
Experiments were carried out in triplicate, and medium was 
changed on alternate days. Gels were harvested at indicated 
time points by fixation in 4% formaldehyde overnight 
at room temperature. Gels were then briefly washed in 
1x PBS, bisected and put in 70% ethanol. Finally, gel 
organotypic tissue was paraffin-embedded and processed 
for immunohistochemistry at the Pathology Core Facility 
of Blizard Institute of Cell and Molecular Science (Barts 
and The London School of Medicine and Dentistry). Cells 
were defined as being invasive and/or invaded, when they 
were detected (double positive for anti-pan-Cytokeratin 
and DAPI) below the collagen/epithelial interface of 
the organotypic gel. Both cell lines (CA1, Luc4) used 
in this study formed a relatively uniform basal layer of 
the re-constructed epithelium. Immnohistochemistry with 
anti-Pan-Cytokeratin allows the visualisation of the 
epithelial architecture, and thus the lower part of the basal 
epithelial layer could be easily identified. 
Plasmid construction
The retroviral vector pSIN-IP-GFP (Self-Inactivating-
Internal Promoter-Green Fluorescence Protein [20] 
vector kindly provided by Dr. Paul Khavari (Stanford 
University School of Medicine, California, USA). In some 
experiments, the pSIN-MCS (MCS) empty viral vector 
bearing no transgene was used as an additional control. 
Transduction of MCS or EGFP did not produce any 
detectable biological artefacts in any of the experiments.
Clonogenic assays and cell counting
Keratinocytes were counted using CAsy® Cell 
Counter (Innovatis). Each sample was prepared three 
times in CAsyTon® (Innovatis) buffer and triplicate 
measurements of 200 μl sample volume were taken each 
time. . Population doublings were calculated as follows: 
PD = 3.32 * [log10 (N1) – log10 (N0)] where N1 = total 
yield and N0 = initial number of seeded keratinocytes. 
Clonogenicity percentages were calculated as follows: 
Clonogenicity % = VC × 100/N0 where VC = visible 
colonies and N0 = initial number of keratinocytes. For 
colony forming assays, keratinocyte cultures were washed 
once with PBS and were fixed in 4% (v/v) formaldehyde 
in PBS for 20 minutes at room temperature. Cells were 
washed 1x with PBS and stained with 1% Rhodamine 
B (Sigma, Dorset, UK) in PBS for 30 minutes at room 
temperature. Colony area coverage measurements were 
performed using Adobe Photoshop CS4 and CorelDraw 
X by using the color selection tool to acquire quantitative 
pixel counts. Clonogenic assays were carried out in 6 
replicate wells for each sample. 
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Fluorescence activated cell sorting 
Fluorescence activated cell sorting experiments 
were performed on BD FACSAria Cell-Sorter (BD 
Biosciences) at Blizard Flow Cytometry core facility by 
Dr. Gary Warnes. For fluorescence activated cell sorting, 
cells were tyrpsinised and washed once with cold PBS 
and then re-suspended in cold FACS buffer consisting 
of PBS with 5% foetal bovine serum (FirstLink), and 
1% penicillin/streptomycin (Gibco Invitrogen). Cells 
were then stained by direct immunofluorescence for 
15 minutes on ice with either PE conjugated anti-CD44 
β1 (BD Biosciences), APC conjugated anti-ESA (BD 
Biosciences) or both at a concentration of 10 μl/106 cells 
in 100 μl of FACS buffer. Cells were spun at low speed 
centrifugation at 140x g for 3 minutes, washed once in 
cold PBS, spun again at 140x g for 3 minutes, and finally 
re-suspended in cold FACS buffer containing 200 ng/ml 
DAPI (DAPI dilactate – Sigma) for dead cell exclusion 
during analysis. DAPI positive cells were gated out and 
fractions were sorted by selecting the highest/lowest 20% 
of CD44-stained cells or high/low populations stained 
with anti-ESA antibody. Control sorted populations were 
selected by sorting randomly from the total pool of DAPI 
negative cells. Keratinocytes were then plated through the 
automated cell dispenser to achieve maximum accuracy, 
directly on 6-well plates at concentrations ranging from 
of 54 – 1x103/cm2 for clonogenic assays, or as required.
Retroviral transduction
Phoenix packaging (PhxA) cells were plated in 
10 cm dishes and were transfected with 10 μg of DNA 
(pSIN-EGFP, pSIN-MCS (emptly vector containing the 
multiple cloning site), using FuGENE 6 reagent (Roche) 
according to manufacturer’s instructions. Transfected 
Phoenix cells were incubated for 48 hrs and then 
sub-cultured in selection medium with puromycin 
(3 ug/ml) (Sigma Aldrich). Cells were maintained in 
selection medium for 1 week. Target cells were pre-
incubated for 5 minutes in growth medium containing 
5 µg/ml polybrene (hexadimethrine bromide; Sigma) 
before replacing with retroviral supernatant containing 
the same concentration of polybrene to facilitate infection. 
The cells in culture dishes with viral supernatant were then 
centrifuged (350x g) at 32°C for 1 hour before retroviral 
supernatant was replaced with normal growth medium and 
kept in normal culture condition. 
Immunoblotting
Protein extraction and separation on SDS-PAGE 
gels and immunoblotting was performed as previously 
described (5). The isolation and irradiation of separate 
populations from CA1 and Luc4 cell lines was repeated 
twice. Each set of samples (two sets) was immunoblotted 
twice. Primary antibodies used were rabbit anti-phospho-
CHK2 (Thr68) (Cell Signaling), rabbit anti-phospho-ATM 
(Ser1981) (Cell Signaling), rabbit anti-phospho-ATR 
(Ser428) (Cell Signaling), rabbit anti-RAD50 (Cell 
Signaling), rabbit anti-RAD52 (Cell Signaling), rabbit 
anti-phospho-BRCA1 (Ser1524), rabbit anti-XLF (Cell 
Signaling), and mouse anti-β-Actin (Sigma). Secondary 
antibodies used were polyclonal rabbit anti-mouse 
immunoglobulin/HRP (DakoCytomation), and polyclonal 
goat anti-rabbit immunoglobulin/HRP (DakoCytomation). 
Densitometry was performed on scanned immunoblot 
images using the ImageJ gel analysis tool [21]. The gel 
analysis tool was used to obtain the absolute intensity 
for each experimental protein band and its corresponding 
protein loading (β-Actin) control band.
Annexin V staining
Annexin V staining on isolated fractions of oral 
cancer cells, following irradiation, was performed as 
previously described [22].
Immunohistochemistry, fluorescence microscopy 
and digital pixel densitometry
Organotypic sections were initially heated at 60oC 
for eight minutes. Sections were then deparaffinised in 
Xylene (3x for 5 minutes) and then dehydrated in (95% 
ethanol, 90% ethanol, 70% ethanol for 5 minutes each) 
and finally rehydrated by incubating for 5 minutes in 
water. Antigen unmasking was performed by incubating 
sections in sub-boiling temperature for 20 minutes in high 
pH (9.0) antigen retrieval solution (DakoCytomation). 
The sections were allowed to cool to room temperature 
for 30 minutes before washing 2x in TBS 0.025% 
tween-20 (Sigma) and were then permeabilised with 
TBS 0.2% Triton-X (Sigma) for 10 minutes at room 
temperature. Protein blocking was performed by 1 hour 
incubation in 10% Goat Serum (Sigma) in TBS (0.025% 
Tween-20) at room temperature. Primary antibody 
probing was performed by overnight incubation at 4oC 
in 1%BSA TBS (0.025% Tween-20). Sections were then 
washed 3x in TBS (0.025% Tween-20) and probed with 
fluorescence conjugated secondary antibodies (diluted 
in 1% BSA in TBS 0.025% Tween-20) for 1 hour at 
room temperature. Finally sections were washed 3x 
in TBS 0.025% Tween-20 and mounted with Shadon 
Immu-MountTM (Thermo Scientific) solution cotaining 
DAPI (DAPI dilactate – Sigma) at a final concentration 
of 300 ng/ml. For frozen section staining, the fixation 
protocols included 4% (vol/vol) formaldehyde in PBS 
for 20 minutes at room temperature or ice cold methanol: 
acetone (1:1) for 10 minutes at room temperature. The 
staining procedure was thereafter the same as mentioned 
above for paraffin embedded tissues. Antibodies used for 
immune-fluorescence were mouse anti-γH2A.Xantibody 
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(clone JBW301K;Millipore), rabbit anti-phosho-CHK2 
(Cell Signaling), rabbit monoclonal anti-EGFP (Cell 
Signaling), mouse anti-Vimentin (Dako) on paraffin 
sections as described [23]. The reaction product was 
visualised with Alexa Fluor 488 goat anti-rabbit IgG, and 
546 secondary antibodies (Molecular Probles, Invitrogen, 
Paisley, UK) for fluorescence microscopy imaging in 
cultured cells. Whilst we have also used ImageJ program 
for pixel densitometry, foci and cell counting and obtained 
similar results, Photoshop was the preferred choice for its 
accuracy, reproducibility and ease of use.
Cell viability and anchorage-independent cell 
transformation assay
CellTiter-GloTM luminescent assay (Promega, 
Madison, WI, USA) was performed according to 
manufacturer’s instruction to quantify ATP levels of 
metabolically active adherent cells. Sphere formation 
assays were performed as described previously [24].
ACKNOWLEDGMENTS
We thank Gary Warnes for technical assistance with 
fluorescence activated cell sorting and Anthony Price for 
assistance with ionising radiation treatment of tumor cells 
and organotypic tissues. 
This work was supported by the National Centre for 
the Replacement, Refinement and Reduction of Animals 
in research, by The Barts and The London Charity, and by 
the Fanconi Anemia Research Foundation.
CONFLICTS OF INTEREST
The authors declare no competing financial interests.
REFERENCES
 1. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, 
Clarke MF. Prospective identification of tumorigenic 
breast cancer cells. Proc Natl Acad Sci U S A. 2003; 
100:3983–3988.
 2. Bonnet D, Dick JE. Human acute myeloid leukemia is 
organized as a hierarchy that originates from a primitive 
hematopoietic cell. Nat Med. 1997; 3:730–737.
 3. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. 
Prospective identification of tumorigenic prostate cancer 
stem cells. Cancer Res. 2005; 65:10946–10951.
 4. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, 
et al. A cell initiating human acute myeloid leukaemia 
after transplantation into SCID mice. Nature. 1994; 
367:645–648.
 5. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, et al. 
Identification of pancreatic cancer stem cells. Cancer Res. 
2007; 67:1030–1037.
 6. O’Brien CA, Pollett A, Gallinger S, Dick JE. A human 
colon cancer cell capable of initiating tumour growth in 
immunodeficient mice. Nature. 2007; 445:106–110.
 7. Park J, Schwarzbauer JE. Mammary epithelial cell 
interactions with fibronectin stimulate epithelial-
mesenchymal transition. Oncogene. 2013;
 8. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, 
Kaplan MJ, et al. Identification of a subpopulation of 
cells with cancer stem cell properties in head and neck 
squamous cell carcinoma. Proc Natl Acad Sci U S A. 
2007;104:973–978.
 9. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, 
cancer, and cancer stem cells. Nature. 2001; 414:105–111.
10. Nguyen LV, Vanner R, Dirks P, Eaves CJ. Cancer stem cells: 
an evolving concept. Nat Rev Cancer. 2012; 12:133–143.
11. Pajonk F, Vlashi E, McBride WH. Radiation resistance of 
cancer stem cells: the 4 R’s of radiobiology revisited. Stem 
Cells. 2010; 28:639–648.
12. Harari PM. Promising new advances in head and neck 
radiotherapy. Ann Oncol 16 Suppl 6:vi13-vi19: 2005.
13. Harper JW, Elledge SJ. The DNA damage response: 
ten years after. Mol Cell. 2007; 28:739–745.
14. Phillips TM, McBride WH, Pajonk F. The response of 
CD24(-/low)/CD44+ breast cancer-initiating cells to 
radiation. J Natl Cancer Inst. 2006; 98:1777–1785.
15. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, et al. 
Association of reactive oxygen species levels and 
radioresistance in cancer stem cells. Nature. 2009; 458: 
780–783.
16. Woodward WA, Chen MS, Behbod F, Alfaro MP, 
Buchholz TA, et al. WNT/beta-catenin mediates radiation 
resistance of mouse mammary progenitor cells. Proc Natl 
Acad Sci U S A. 2007; 104:618–623.
17. Chen MS, Woodward WA, Behbod F, Peddibhotla S, 
Alfaro MP, et al. Wnt/beta-catenin mediates radiation 
resistance of Sca1+ progenitors in an immortalized 
mammary gland cell line. J Cell Sci. 2007; 120:468–477.
18. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. Glioma 
stem cells promote radioresistance by preferential activation 
of the DNA damage response. Nature. 2006; 444:756–760.
19. Biddle A, Liang X, Gammon L, Fazil B, Harper LJ, 
et al. Cancer stem cells in squamous cell carcinoma switch 
between two distinct phenotypes that are preferentially 
migratory or proliferative. Cancer Res. 2011; 71:5317–5326.
20. Deng H, Lin Q, Khavari PA. Sustainable cutaneous gene 
delivery. Nat Biotechnol. 1997; 15:1388–1391.
21. Abramoff MDM, Paulo JR, Sunanda J. Image Processing 
with ImageJ. Biophotonics International. 2004; 11:36–42.
22. Pantazi E, Gemenetzidis E, Trigiante G, Warnes G, Shan L, et 
al. GLI2 induces genomic instability in human keratinocytes 
by inhibiting apoptosis. Cell Death Dis. 2014; 5:e1028.
23. Ghali L, Wong ST, Green J, Tidman N, Quinn AG. Gli1 
protein is expressed in basal cell carcinomas, outer root 
sheath keratinocytes and a subpopulation of mesenchymal 
Oncotarget14www.impactjournals.com/oncotarget
cells in normal human skin. J Invest Dermatol. 1999; 
113:595–599.
24. Gammon L, Biddle A, Heywood HK, Johannessen AC, 
Mackenzie IC. Sub-sets of cancer stem cells differ 
intrinsically in their patterns of oxygen metabolism. PLoS 
One. 2013; 8:e62493.
25. Biddle A, Gammon L, Fazil B, Mackenzie IC. CD44 
staining of cancer stem-like cells is influenced by down-
regulation of CD44 variant isoforms and up-regulation of 
the standard CD44 isoform in the population of cells that 
have undergone epithelial-to-mesenchymal transition. PLoS 
One. 2013; 8:e57314.
26. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, et al. 
Activation of the ATM kinase by ionizing radiation and 
phosphorylation of p53. Science. 1998; 281:1677–1679.
27. Falck J, Mailand N, Syljuasen RG, Bartek J, Lukas J. The 
ATM-Chk2-Cdc25A checkpoint pathway guards against 
radioresistant DNA synthesis. Nature. 2001; 410:842–847.
28. Cliby WA, Roberts CJ, Cimprich KA, Stringer CM, Lamb JR, 
et al. Overexpression of a kinase-inactive ATR protein 
causes sensitivity to DNA-damaging agents and defects in 
cell cycle checkpoints. EMBO J. 1998; 17:159–169.
29. Momcilovic O, Knobloch L, Fornsaglio J, Varum S, Easley C, 
et al. DNA damage responses in human induced pluripotent 
stem cells and embryonic stem cells. PLoS One. 2010; 
5:e13410.
30. Wang WJ, Wu SP, Liu JB, Shi YS, Huang X, et al. MYC 
regulation of CHK1 and CHK2 promotes radioresistance 
in a stem cell-like population of nasopharyngeal carcinoma 
cells. Cancer Res. 2013; 73:1219–1231.
31. Barlow JH, Rothstein R. Timing is everything: cell cycle 
control of Rad52. Cell Div. 2010; 5:7.
32. Park MS. Expression of human RAD52 confers resistance 
to ionizing radiation in mammalian cells. J Biol Chem. 
1995; 270:15467–15470.
33. Tarsounas M, Davies D, West SC. BRCA2-dependent and 
independent formation of RAD51 nuclear foci. Oncogene. 
2003; 22:1115–1123.
34. Cramer-Morales K, Nieborowska-Skorska M, Scheibner K, 
Padget M, Irvine DA, et al. Personalized synthetic lethality 
induced by targeting RAD52 in leukemias identified 
by gene mutation and expression profile. Blood. 2013; 
122:1293–1304.
35. Celeste A, Fernandez-Capetillo O, Kruhlak MJ, Pilch DR, 
Staudt DW, et al. Histone H2AX phosphorylation is 
dispensable for the initial recognition of DNA breaks. Nat 
Cell Biol. 2003; 5:675–679.
36. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, 
Gellert M, et al. A critical role for histone H2AX in 
recruitment of repair factors to nuclear foci after DNA 
damage. Curr Biol. 2000; 10:886–895.
37. Barrandon Y, Green H. Three clonal types of keratinocyte 
with different capacities for multiplication. Proc Natl Acad 
Sci U S A. 1987; 84:2302–2306.
38. Harper LJ, Costea DE, Gammon L, Fazil B, Biddle A, 
et al. Normal and malignant epithelial cells with stem-
like properties have an extended G2 cell cycle phase that 
is associated with apoptotic resistance. BMC Cancer. 
2010; 10:166.
39. Jechlinger M, Grunert S, Beug H. Mechanisms in epithelial 
plasticity and metastasis: insights from 3D cultures and 
expression profiling. J Mammary Gland Biol Neoplasia. 
2002; 7:415–432.
40. Kalluri R, Weinberg RA. The basics of epithelial-
mesenchymal transition. J Clin Invest. 2009; 119:1420–1428.
41. Shi Y, Massague J. Mechanisms of TGF-beta signaling from 
cell membrane to the nucleus. Cell. 2003;113:685–700.
42. Gomez-Casal R, Bhattacharya C, Ganesh N, Bailey L, Basse P, 
et al. Non-small cell lung cancer cells survived ionizing 
radiation treatment display cancer stem cell and epithelial-
mesenchymal transition phenotypes. Mol Cancer. 2013; 12:94.
43. Yuan W, Yuan Y, Zhang T, Wu S. Role of bmi-1 in regulation 
of ionizing irradiation-induced epithelial-mesenchymal 
transition and migration of breast cancer cells. PLoS One. 
2015; 10:e0118799.
